Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,904 | 76,677 | 109,306 | 78,221 | 63,608 |
| Marketable Securities | N/A | N/A | N/A | 50 | N/A |
| TOTAL | $74,506 | $78,263 | $110,942 | $79,749 | $64,925 |
| Non-Current Assets | |||||
| PPE Net | 364 | 550 | 604 | 340 | 312 |
| Investments And Advances | 0 | 0 | 0 | 0 | 50 |
| Other Non-Current Assets | 2,029 | 2,632 | 2,646 | 299 | 1,110 |
| TOTAL | $2,393 | $3,182 | $3,250 | $639 | $1,472 |
| Total Assets | $76,899 | $81,445 | $114,192 | $80,388 | $66,397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,568 | 7,953 | 10,130 | 5,535 | 4,340 |
| TOTAL | $8,148 | $8,494 | $10,628 | $6,840 | $4,767 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 998 | N/A |
| Other Non-Current Liabilities | 984 | 1,553 | 2,083 | 0 | 245 |
| TOTAL | $35,993 | $36,572 | $37,083 | $3 | $311 |
| Total Liabilities | $44,141 | $45,066 | $47,711 | $6,843 | $5,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,196 | 29,396 | 25,729 | 22,144 | 19,246 |
| Common Shares | 31 | 28 | 26 | 22 | 18 |
| Retained earnings | -375,826 | -337,583 | -288,765 | -255,748 | -230,974 |
| TOTAL | $32,758 | $36,379 | $66,481 | $73,545 | $61,319 |
| Total Liabilities And Equity | $76,899 | $81,445 | $114,192 | $80,388 | $66,397 |